NCT01298622

Brief Summary

To investigate the structural/functional abnormalities and the possible genetic endophenotypes of Obsessive-compulsive disorder (OCD) patients and their core families.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2011

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2011

Completed
16 days until next milestone

First Submitted

Initial submission to the registry

February 17, 2011

Completed
1 day until next milestone

First Posted

Study publicly available on registry

February 18, 2011

Completed
11.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2022

Completed
Last Updated

September 17, 2019

Status Verified

September 1, 2019

Enrollment Period

11.8 years

First QC Date

February 17, 2011

Last Update Submit

September 14, 2019

Conditions

OCD

Outcome Measures

Primary Outcomes (1)

  • Y-BOCS

    Y-BOCS

Study Arms (3)

controls

OCD patients

OCD parents

Eligibility Criteria

Age15 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

OCD patients and their parents

You may qualify if:

  • diagnosed OCD patient

You may not qualify if:

  • organic disease
  • other psychiatric disorder

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Psychiatry department of KMC

Kunming, Yunnan, 650032, China

RECRUITING

Biospecimen

Retention: SAMPLES WITH DNA

perapheral blood DNA of all participants

Study Officials

  • Xiufeng Xu

    the 1st affiliated hospital of Kunming medical college

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
CROSS SECTIONAL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
prof.

Study Record Dates

First Submitted

February 17, 2011

First Posted

February 18, 2011

Study Start

February 1, 2011

Primary Completion

December 1, 2022

Study Completion

December 1, 2022

Last Updated

September 17, 2019

Record last verified: 2019-09

Locations

CN(1)